Beacon Financial Advisory’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$439K Buy
1,249
+44
+4% +$15.7K 0.1% 249
2025
Q4
$394K Buy
1,205
+75
+7% +$23.8K 0.09% 247
2025
Q3
$319K Buy
1,130
+152
+16% +$44.1K 0.07% 283
2025
Q2
$273K Buy
978
+117
+14% +$33.1K 0.07% 282
2025
Q1
$268K Buy
861
+88
+11% +$26K 0.08% 258
2024
Q4
$201K Buy
773
+4
+0.5% +$1.19K 0.07% 286
2024
Q3
$248K Buy
769
+34
+5% +$11.1K 0.08% 251
2024
Q2
$230K Buy
+735
New +$216K 0.09% 247
2021
Q4
Sell
-1,239
Closed -$263K 243
2021
Q3
$263K Buy
+1,239
New +$285K 0.14% 186

Other funds holding AMGN

Beacon Financial Advisory's AMGN Position: Q1 2026 in Review

Beacon Financial Advisory increased its Amgen (AMGN) stake by 3.7% in Q1 2026, buying an estimated $15.7K and bringing the position to 1,249 shares worth $439K. The position accounts for 0.1% of the portfolio, ranked #249.

Beacon Financial Advisory first reported a position in AMGN in Q3 2021 and has held it in 9 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Beacon Financial Advisory held 1,249 shares of Amgen worth $439K as of Q1 2026.
  • Beacon Financial Advisory bought 44 Amgen shares in Q1 2026, an estimated $15.7K.
  • Amgen made up 0.1% of Beacon Financial Advisory's portfolio in Q1 2026, its #249 holding.
  • Beacon Financial Advisory first reported a position in Amgen in Q3 2021 and has held it in 9 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Beacon Financial Advisory's 13F filing for Q1 2026, filed 27 Apr 2026.